WebCellCept ® (mycophenolate mofetil) is a prescription medicine to prevent rejection (antirejection medicine) in people who have received a kidney, heart or liver transplant. … WebMycophenolate (CellCept) is used with other medications to help prevent transplant organ rejection (attack of the transplanted organ by the immune system of the person receiving the organ) in adults and children 3 months of age and older who have received kidney, heart, or liver transplants. Mycophenolate (Myfortic) is used with other ...
Pharmacologic treatment of ILD Interstitial Lung Disease (ILD ...
WebFeb 3, 2024 · Mycophenolate mofetil is an antimetabolite and potent immunosuppressive agent used as adjunctive therapy in prevention of allograft rejection and in the treatment … WebMay 3, 1995 · Mycophenolate mofetil (CellCept) is a drug prescribed for the prophylaxis of organ rejection in people receiving kidney, heart, or liver transplants. Side effects, drug … pottery barn recliner sofa
Polymyositis - Diagnosis and treatment - Mayo Clinic
WebRare side effects include liver damage, pancreas inflammation (pancreatitis) and cancer. Other immunosuppressants. If you don't respond to prednisone or azathioprine, your … WebFind patient medical information for CellCept oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. ... especially of: cancer, liver disease ... WebMay 3, 1995 · Mycophenolate mofetil (CellCept) is a drug prescribed for the prophylaxis of organ rejection in people receiving kidney, heart, or liver transplants. Side effects, drug interactions, warnings, precautions, dosing, storage, pregnancy, and breastfeeding safety information should be reviewed prior to taking this drug. ... Liver disease can be ... touhou background